| Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis (NCT05407246) | Tianjin Hemay Pharmaceutical Co., Ltd | 2022-08-05 |
| A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis (NCT04839328) | Tianjin Hemay Pharmaceutical Co., Ltd | 2022-01-20 |
| A Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer (NCT06313983) | Tianjin Hemay Pharmaceutical Co., Ltd | 2022-01-08 |
| Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects (NCT04837235) | Tianjin Hemay Pharmaceutical Co., Ltd | 2021-04-29 |
| A Phase 2 Study of Hemay007 in Patients With Rheumatoid Arthritis (NCT05247216) | Tianjin Hemay Pharmaceutical Co., Ltd | 2021-03-26 |
| A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease (NCT04609397) | Tianjin Hemay Pharmaceutical Co., Ltd | 2020-11-30 |
| A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients (NCT04352595) | Tianjin Hemay Pharmaceutical Co., Ltd | 2020-04-24 |
| Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis (NCT03977480) | Tianjin Hemay Pharmaceutical Co., Ltd | 2019-08-13 |
| Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis (NCT04102241) | Tianjin Hemay Pharmaceutical Co., Ltd | 2019-05-30 |
| A Phase I Clinical Study of Hemay808 (NCT04100642) | Tianjin Hemay Pharmaceutical Co., Ltd | 2019-04-08 |
| Study Evaluating Hemay022 in Combination With Endocrine Therapy In Subjects With ER Positive and HER2 Positive Advanced Breast Cancer (NCT03308201) | Tianjin Hemay Pharmaceutical Co., Ltd | 2017-10-16 |